PAR 0.00% 22.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 121 Posts.
    lightbulb Created with Sketch. 31
    The fact that they are forecasting a 7 million dollar September quarter would indicate that the phase 3 will not be starting until at least October.
    If the pase 3 does start in October and no deal has been done, then expect a CR the day after phase 3 approval.
    This is time for Paul to make good on his promises of deals, if he cant then I dont know how they are expect to fund the phase III.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 22.5¢ 22.0¢ $34.69K 154.9K

Buyers (Bids)

No. Vol. Price($)
1 28174 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 25000 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.